Josh Jennings
Stock Analyst at TD Cowen
(3.73)
# 2,059
Out of 4,974 analysts
1144
Total ratings
46.6%
Success rate
3.5%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Reiterated: Buy | $110 | $93.80 | +17.27% | 74 | Sep 15, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $135 | $103.09 | +30.95% | 76 | Sep 14, 2026 | |
| BFLY Butterfly Network | Reiterated: Buy | $10 | $7.41 | +34.95% | 34 | Sep 11, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $120 | $85.86 | +39.76% | 73 | Sep 8, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $56 | $45.05 | +24.31% | 82 | Sep 4, 2026 | |
| VCEL Vericel | Reiterated: Buy | $58 | $39.60 | +46.46% | 25 | Sep 4, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $117 | $71.92 | +62.68% | 54 | Sep 2, 2026 | |
| CERS Cerus | Reiterated: Buy | $5 | $2.55 | +96.08% | 38 | Aug 28, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1.25 | $0.561 | +122.82% | 48 | Aug 19, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $12 → $14 | $10.19 | +37.39% | 35 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $182 | $182.91 | -0.50% | 23 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $13.88 | +80.12% | 29 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $1.33 | +125.56% | 30 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $3.15 | +217.46% | 30 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.84 | +69.68% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $24.33 | +19.19% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $28 | $21.02 | +33.21% | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $29 | $23.86 | +21.54% | 39 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $84.68 | +12.19% | 41 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $104 | $85.52 | +21.61% | 72 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.72 | +72.02% | 11 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $5.90 | +154.24% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $266.32 | -6.13% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $20 | $10.86 | +84.16% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $137.80 | +175.04% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.03 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $435 | $281.87 | +54.33% | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $1.21 | +7,344.17% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.81 | +18.98% | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $104 → $99 | $96.54 | +2.55% | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2453 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.07 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24.91 | $8.03 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $13 | $0.8299 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $146.41 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $1.06 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.0001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7964 | n/a | 1 | Mar 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $0.000001 | n/a | 1 | Aug 30, 2013 |
Medtronic
Sep 15, 2026
Reiterated: Buy
Price Target: $110
Current: $93.80
Upside: +17.27%
Abbott Laboratories
Sep 14, 2026
Reiterated: Buy
Price Target: $135
Current: $103.09
Upside: +30.95%
Butterfly Network
Sep 11, 2026
Reiterated: Buy
Price Target: $10
Current: $7.41
Upside: +34.95%
TransMedics Group
Sep 8, 2026
Reiterated: Buy
Price Target: $120
Current: $85.86
Upside: +39.76%
Boston Scientific
Sep 4, 2026
Reiterated: Buy
Price Target: $56
Current: $45.05
Upside: +24.31%
Vericel
Sep 4, 2026
Reiterated: Buy
Price Target: $58
Current: $39.60
Upside: +46.46%
Establishment Labs Holdings
Sep 2, 2026
Reiterated: Buy
Price Target: $117
Current: $71.92
Upside: +62.68%
Cerus
Aug 28, 2026
Reiterated: Buy
Price Target: $5
Current: $2.55
Upside: +96.08%
Humacyte
Aug 19, 2026
Reiterated: Buy
Price Target: $1.25
Current: $0.561
Upside: +122.82%
AVITA Medical
Aug 19, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $10.19
Upside: +37.39%
Aug 17, 2026
Rated: Hold
Price Target: $182
Current: $182.91
Upside: -0.50%
Aug 14, 2026
Reiterated: Buy
Price Target: $25
Current: $13.88
Upside: +80.12%
Aug 12, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $1.33
Upside: +125.56%
Aug 7, 2026
Rated: Buy
Price Target: $10
Current: $3.15
Upside: +217.46%
Aug 7, 2026
Reiterated: Buy
Price Target: $15
Current: $8.84
Upside: +69.68%
Aug 5, 2026
Reiterated: Buy
Price Target: $29
Current: $24.33
Upside: +19.19%
Aug 5, 2026
Rated: Buy
Price Target: $34 → $28
Current: $21.02
Upside: +33.21%
Jul 31, 2026
Reiterated: Hold
Price Target: $24 → $29
Current: $23.86
Upside: +21.54%
Jul 30, 2026
Reiterated: Buy
Price Target: $95
Current: $84.68
Upside: +12.19%
Jul 23, 2026
Rated: Buy
Price Target: $104
Current: $85.52
Upside: +21.61%
Jun 29, 2026
Reiterated: Buy
Price Target: $15
Current: $8.72
Upside: +72.02%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $5.90
Upside: +154.24%
Apr 23, 2026
Reiterated: Buy
Price Target: $250
Current: $266.32
Upside: -6.13%
Jan 23, 2026
Reiterated: Buy
Price Target: $27 → $20
Current: $10.86
Upside: +84.16%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $137.80
Upside: +175.04%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.03
Upside: -
Nov 13, 2025
Reiterated: Buy
Price Target: $435
Current: $281.87
Upside: +54.33%
Nov 12, 2025
Reiterated: Buy
Price Target: $90
Current: $1.21
Upside: +7,344.17%
Nov 6, 2025
Reiterated: Buy
Price Target: $20
Current: $16.81
Upside: +18.98%
Nov 5, 2025
Reiterated: Hold
Price Target: $104 → $99
Current: $96.54
Upside: +2.55%
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.2453
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $6.07
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $24.91
Current: $8.03
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $15 → $13
Current: $0.8299
Upside: n/a
Oct 29, 2020
Reiterated: Buy
Price Target: $80
Current: $146.41
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $1.06
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.0001
Upside: n/a
Mar 18, 2015
Reiterated: Buy
Price Target: $9
Current: $0.7964
Upside: n/a
Aug 30, 2013
Initiated Coverage: Buy
Price Target: $3.5
Current: $0.000001
Upside: n/a